APA (7th ed.) Citation

Gomez-Gomez, E., Moreno Sorribas, S., Valero-Rosa, J., Blanca, A., Mesa, J., Salguero, J., . . . Anglada-Curado, F. J. (2021). Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy? Diagnostics (2075-4418), 11(8), 1335. https://doi.org/10.3390/diagnostics11081335

Chicago Style (17th ed.) Citation

Gomez-Gomez, Enrique, Sara Moreno Sorribas, Jose Valero-Rosa, Ana Blanca, Juan Mesa, Joseba Salguero, Julia Carrasco-Valiente, Daniel López-Ruiz, and Francisco José Anglada-Curado. "Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?" Diagnostics (2075-4418) 11, no. 8 (2021): 1335. https://doi.org/10.3390/diagnostics11081335.

MLA (9th ed.) Citation

Gomez-Gomez, Enrique, et al. "Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?" Diagnostics (2075-4418), vol. 11, no. 8, 2021, p. 1335, https://doi.org/10.3390/diagnostics11081335.